| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |